@CEOPaterson Profile picture

Wayne Paterson

@CEOPaterson

CEO of @Anteris $AVR. 25 years building #healthcare businesses around the world. Passionate about #medtech’s potential for people.

Similar User
Anteris Technologies photo

@AnterisTech

TRANSEARCH USA photo

@TRANSEARCH_USA

Doreen Finkle photo

@USABetterFuture

Jacquie Rougeau photo

@SpiceDivaCEO

Michael A. Romig in Austin, Texas, USA photo

@MichaelRomig

Tom Cahill 🌈🌈 photo

@CahillT1

Sarah Downey photo

@SarahEDowney1

Shane Degaris photo

@shanedegaris

Kazuhide Shaun Okuda photo

@Kazebrafish

Gbenga George (Esq.) photo

@Gbengag

Dan Corry photo

@DanRCorry

Maxine J Tulloch, MB photo

@Tullochmj

Susan Richards photo

@SRRAtlanta

Samuel Bistrian photo

@SamuelBistrian

Dedric Holmes photo

@DedricHolmes

Wayne Paterson Reposted

Thank you @mirvatalasnag for capturing this. Privileged to be working w/ @HEARTinMagnet on this, and excited to understand the clinical implications #DurAVR flow pattern might have. @CEOPaterson @chrismeduri @azeemlatib @bapat_savrtavr @AnterisTech @SusheelKodaliMD @SCMRorg


Excited to present to our shareholders at our AGM in Sydney tomorrow and look forward to seeing you there #proudtobeanteris#DurAVR#


Wayne Paterson Reposted

Watch this physician panel to hear Drs @MReardon19 , @chrismeduri , and @azeemlatib discuss the design of the DurAVR™ transcatheter heart valve and the paradigm-shifting hemodynamic results from the US Early Feasibility Study (EFS): anteristech.com/home.html

Tweet Image 1

Further evidence that DurAVR™ the first in class biomimetic valve built on the Adapt® tissue platform is showing exceptional results due to its novel valve design and superior tissue science whilst maintaining more predictable delivery with a novel BE platform #valvedesign

#PCRLV: @azeemlatib presents insights from the first in man implant of the DurAVR biomimetic TAVI valve (@AnterisTech). He reports that the device had a favourable safety profile, and “outstanding” haemodynamic performance

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4


Wayne Paterson Reposted

#PCRLV: @azeemlatib presents insights from the first in man implant of the DurAVR biomimetic TAVI valve (@AnterisTech). He reports that the device had a favourable safety profile, and “outstanding” haemodynamic performance

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Wayne Paterson Reposted

⭐️ FIH & EFS data on DurAVR just presented by @azeemlatib #PCRLV 🎯Balloon-expandable 🎯Commissure-alignment 🎯Long coaptation length 🎯EXCELLENT Hemodynamics @chrismeduri @AnterisTech @MonteHeart

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Wayne Paterson Reposted

Last week Stephanie Sellers presented bench testing results from the novel DurAVR™ THV at #TCT2023. DurAVR demonstrated superior hemodynamic performance in Redo-TAVR procedures. Learn more about DurAVR here: links.anteristech.com/3S0KANs #TAVR #TAVI #innovation #AnterisTech

Tweet Image 1
Tweet Image 2

Wayne Paterson Reposted

Is this aortic flow normal? Two papers will help to understand the pathophysiological aetiology better - academic.oup.com/ehjopen/articl… nature.com/articles/s4156… Aortic flow MATTERS. 💯


Great way to end a great week. Meeting with the V2V team to discuss our unique TEER device for mitral repair.Thanks to the Anteris team for all the work that culminated in a great #TCT for #AVR #movingtheconversationforward #proudtobeanteris

Tweet Image 1
Tweet Image 2
Tweet Image 3

Wayne Paterson Reposted

$AVR one of the unique distinguishing features of #DurAVR is the return of near perfect laminar flow. This impacts on valve durability, performance +. As > evidence emerges this will become a required expectation in valve performance. No other valve achieves this. #TAVR #TCT2023

An insight into why aortic flow is becoming a novel therapeutic target. In collaboration with world experts in aortic physiology. @NatureNews @NatRevCardiol @Nature #WhyCMR #4DFlowCMR Thanks ALL (@chrismeduri) and legendary Michael Markl! Paper ⬇️ nature.com/articles/s4156…

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4


Great week at TCT with incredible data being presented by Anteris demonstrating superior MPG's ,superior EOA's and superior DVI's to current therapies. A huge thanks to our team,Physicians and patients. We are moving the conversation forward ! #proudtobeanteris #DurAVR

Tweet Image 1

Wayne Paterson Reposted

It's been an exciting day of TAVR data at #TCT2023, with major updates on #TAVR studies! It's clear that valve performance matters. Tune in this afternoon for DurAVR™ THV US EFS discharge data -- moving the conversation forward with paradigm-shifting hemodynamic performance!


Wayne Paterson Reposted

Standing room only! At #TCT2023, @chrismeduri presented the latest data from the DurAVR™ THV FIH Study. Remarkable hemodynamic results are holding steady at 6 months and 1 year post-op! More info: links.anteristech.com/3S0KANs #TAVR #TAVI #clinicaltrial #innovation

Tweet Image 1
Tweet Image 2
Tweet Image 3

Great presentation today by Dr Latib on our US EFS study. Hemodynamics, EOAs, DVI results are unprecedented. #hemodynamicsmatter #valvedesignmatters #proudtobeanteris

Tweet Image 1
Tweet Image 2

DurAVR US EFS results presented @TCTMD by @azeemlatib today In small annuli patients (mean 22.2): ✔️ safe, easy to use ✔️ no pacemakers ✔️ 93% no/trace, 7% mild PVL 🎯mean EOA 2.36 🎯MPG 7.8 🎯DVI 0.71 This groundbreaking, first biomimetic valve will change AS treatment



Wayne Paterson Reposted

Incredible teamwork and support by a world-class SH team. We could not do this without our amazing team: @EdwinHoMD @MeiChau3 @m_assafin @AndreaScotti21 @jimmydoolittle @KaraBoothMonte and her research team @jesusdaiyan @MonteHeart

#AnterisTech announces first patients successfully treated in #DurAVR THV US Early Feasibility Study @azeemlatib performed the cases at @MontefioreNYC $AVR #TAVR #TAVI #Innovation #CardioTwitter #cardiology #heart #doctor #cardiac Full Details: links.anteristech.com/3Ym60G7

Tweet Image 1


Wayne Paterson Reposted

#AnterisTech announces first patients successfully treated in #DurAVR THV US Early Feasibility Study @azeemlatib performed the cases at @MontefioreNYC $AVR #TAVR #TAVI #Innovation #CardioTwitter #cardiology #heart #doctor #cardiac Full Details: links.anteristech.com/3Ym60G7

Tweet Image 1

Wayne Paterson Reposted

#AnterisTech is pleased to announce DurAVR™ FIH abstract has been published in Heart Lung and Circulation as part of the 71st Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, 3-6 August 2023, Adelaide, Australia. Visit: heartlungcirc.org/article/S1443-…

Tweet Image 1

Wayne Paterson Reposted

#AnterisTech is proud to present “DurAVR™ TAVI first-in-human study confirms excellent haemodynamics to 1 year” at #CSANZ2023 #ANZET23

Tweet Image 1

Loading...

Something went wrong.


Something went wrong.